These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT). Ruwald AC; Schuger C; Moss AJ; Kutyifa V; Olshansky B; Greenberg H; Cannom DS; Estes NA; Ruwald MH; Huang DT; Klein H; McNitt S; Beck CA; Goldstein R; Brown MW; Kautzner J; Shoda M; Wilber D; Zareba W; Daubert JP Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):785-92. PubMed ID: 25136077 [TBL] [Abstract][Full Text] [Related]
15. Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial. Gasparini M; Proclemer A; Klersy C; Kloppe A; Lunati M; Ferrer JB; Hersi A; Gulaj M; Wijfels MC; Santi E; Manotta L; Arenal A JAMA; 2013 May; 309(18):1903-11. PubMed ID: 23652522 [TBL] [Abstract][Full Text] [Related]
16. A propensity matched case-control study comparing efficacy, safety and costs of the subcutaneous vs. transvenous implantable cardioverter defibrillator. Honarbakhsh S; Providencia R; Srinivasan N; Ahsan S; Lowe M; Rowland E; Hunter RJ; Finlay M; Segal O; Earley MJ; Chow A; Schilling RJ; Lambiase PD Int J Cardiol; 2017 Feb; 228():280-285. PubMed ID: 27865198 [TBL] [Abstract][Full Text] [Related]
17. Subcutaneous versus transvenous implantable defibrillator: An updated meta-analysis. Rordorf R; Casula M; Pezza L; Fortuni F; Sanzo A; Savastano S; Vicentini A Heart Rhythm; 2021 Mar; 18(3):382-391. PubMed ID: 33212250 [TBL] [Abstract][Full Text] [Related]
18. Subcutaneous versus transvenous implantable defibrillator in patients with hypertrophic cardiomyopathy. Jankelson L; Garber L; Sherrid M; Massera D; Jones P; Barbhaiya C; Holmes D; Knotts R; Bernstein S; Spinelli M; Park D; Aizer A; Chinitz L Heart Rhythm; 2022 May; 19(5):759-767. PubMed ID: 35038570 [TBL] [Abstract][Full Text] [Related]
19. Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Systematic Review and Meta-Analysis of Randomized Trials and Propensity Score-Matched Studies. Fong KY; Ng CJR; Wang Y; Yeo C; Tan VH J Am Heart Assoc; 2022 Jun; 11(11):e024756. PubMed ID: 35656975 [TBL] [Abstract][Full Text] [Related]
20. Head-to-head comparison of arrhythmia discrimination performance of subcutaneous and transvenous ICD arrhythmia detection algorithms: the START study. Gold MR; Theuns DA; Knight BP; Sturdivant JL; Sanghera R; Ellenbogen KA; Wood MA; Burke MC J Cardiovasc Electrophysiol; 2012 Apr; 23(4):359-66. PubMed ID: 22035049 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]